{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-002315","form_type":"8-K/A","ticker":"AGPU","cik":"0001446159","company_name":"Axe Compute Inc.","filed_at":"2025-04-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.317586+00:00","generated_at":"2026-05-23T10:57:13.248271+00:00","sec_items":["7.01","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Predictive Oncology ends merger talks with Renovaro; no binding agreement signed","bullets":["POAI decided to discontinue discussions with RENB regarding the proposed merger.","POAI states it never entered into a merger agreement; RENB's April 4 press release claims were misrepresentations.","The letter of intent with RENB expired on March 31, 2025; POAI has no further obligations.","POAI reaffirms commitment to its AI-driven drug discovery and drug development business."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-002315","json":"https://secwatch.observer/filing/0001171843-25-002315.json","markdown":"https://secwatch.observer/filing/0001171843-25-002315.md","text":"https://secwatch.observer/filing/0001171843-25-002315.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1446159/000117184325002315/0001171843-25-002315-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1446159/000117184325002315/f8ka_041825.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T10:57:13.248271+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}